WO2009005155A1 - 間葉系幹細胞の増殖能・分化能維持方法 - Google Patents
間葉系幹細胞の増殖能・分化能維持方法 Download PDFInfo
- Publication number
- WO2009005155A1 WO2009005155A1 PCT/JP2008/062239 JP2008062239W WO2009005155A1 WO 2009005155 A1 WO2009005155 A1 WO 2009005155A1 JP 2008062239 W JP2008062239 W JP 2008062239W WO 2009005155 A1 WO2009005155 A1 WO 2009005155A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- msc
- differentiation ability
- proliferation
- stem cell
- mesenchymal stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/602—Sox-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/605—Nanog
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
【課題】ヒト成人骨髄由来MSCの増殖能・分化能を維持する方法、或いは増殖能・分化能を維持した間葉系幹細胞、さらには間葉系幹細胞に作用する薬物のスクリーニング方法を開発することを目的とし、間葉系幹細胞(MSC)、特にヒト成人骨髄由来MSCの増殖能・分化能を維持する。 【解決手段】間葉系幹細胞(MSC)、特にヒト成人骨髄由来MSCの増殖能・分化能を維持する方法を提供する。Sox2あるいはNanog遺伝子を導入することで強制的・安定的に遺伝子発現を誘導すること、あるいはSox2遺伝子を導入することと成長因子であるbFGFの培地への添加を併用することにより、MSCの増殖能・分化能を維持することができる。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007177767A JP2009011254A (ja) | 2007-07-05 | 2007-07-05 | 間葉系幹細胞の増殖能・分化能維持方法 |
| JP2007-177767 | 2007-07-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2009005155A1 true WO2009005155A1 (ja) | 2009-01-08 |
Family
ID=40226193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2008/062239 Ceased WO2009005155A1 (ja) | 2007-07-05 | 2008-07-05 | 間葉系幹細胞の増殖能・分化能維持方法 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2009011254A (ja) |
| WO (1) | WO2009005155A1 (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108603167A (zh) * | 2015-09-15 | 2018-09-28 | 思特科技公司 | 使用其中引入nanog的源自羊水胎儿的间充质干细胞制备用于促进毛发生长的组合物的方法 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018131900A2 (ko) * | 2017-01-11 | 2018-07-19 | 주식회사 스템랩 | 나노그를 도입한 양수 내 태아 유래 중간엽 줄기세포로부터 획득한 엑소좀 내 포함된 육모 촉진용 조성물의 제조방법 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005110565A (ja) * | 2003-10-07 | 2005-04-28 | Nobuya Yamanaka | 分化多能性維持剤 |
| WO2007010858A1 (ja) * | 2005-07-15 | 2007-01-25 | Kyoto University | 骨格筋組織由来の単一細胞よりクローン化した多能性幹細胞 |
-
2007
- 2007-07-05 JP JP2007177767A patent/JP2009011254A/ja active Pending
-
2008
- 2008-07-05 WO PCT/JP2008/062239 patent/WO2009005155A1/ja not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005110565A (ja) * | 2003-10-07 | 2005-04-28 | Nobuya Yamanaka | 分化多能性維持剤 |
| WO2007010858A1 (ja) * | 2005-07-15 | 2007-01-25 | Kyoto University | 骨格筋組織由来の単一細胞よりクローン化した多能性幹細胞 |
Non-Patent Citations (7)
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108603167A (zh) * | 2015-09-15 | 2018-09-28 | 思特科技公司 | 使用其中引入nanog的源自羊水胎儿的间充质干细胞制备用于促进毛发生长的组合物的方法 |
| US20180362606A1 (en) * | 2015-09-15 | 2018-12-20 | Stemlab Inc. | Method for preparing composition for promoting hair growth using nanog-introduced mesenchymal stem cells derived from fetus in amniotic fluid |
| US10640541B2 (en) * | 2015-09-15 | 2020-05-05 | Stemlab Inc. | Method for preparing composition for promoting hair growth using Nanog-introduced mesenchymal stem cells derived from fetus in amniotic fluid |
| CN108603167B (zh) * | 2015-09-15 | 2022-01-21 | 思特科技公司 | 使用nanog引入的源自羊水胎儿的间充质干细胞制备用于促进毛发生长的组合物的方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009011254A (ja) | 2009-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gaspar et al. | Progress in cell-based therapies for tendon repair | |
| EP4368701A3 (en) | Feeder-free culture system | |
| WO2008129563A3 (en) | Human mesenchymal stem cells and preparation thereof | |
| WO2010147395A3 (en) | Medium composition comprising neuropeptide y for the generation, maintenance, prologned undifferentiated growth of pluripotent stem cells and method of culturing pluripotent stem cell using the same | |
| WO2010129294A3 (en) | Small molecules supporting pluripotent cell growth and methods thereof | |
| WO2006070370A3 (en) | Stem cells culture systems | |
| WO2012008813A3 (ko) | 양막유래 중간엽 줄기세포 배양을 위한 배지조성물 및 이를 이용한 양막유래 중간엽 줄기세포의 배양방법 | |
| WO2010090513A3 (en) | Culture medium for epithelial stem cells and organoids comprising said stem cells. | |
| GB2454386A (en) | Method for stem cell culture and cells derived therefrom | |
| IL252607B (en) | Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state | |
| NZ592622A (en) | Stem cell aggregate suspension compositions and methods for differentiation thereof | |
| WO2011114237A3 (en) | Composition and method for enabling proliferation of pluripotent human stem cells | |
| MX352337B (es) | Factor de reprogramacion nuclear. | |
| WO2012032521A8 (en) | Novel methods and culture media for culturing pluripotent stem cells | |
| WO2009077134A3 (en) | Use of rna for reprogramming somatic cells | |
| WO2007016566A3 (en) | Production of reprogrammed cells with restored potential | |
| WO2010033088A8 (en) | Method of improving differentiation of chondrogenic progenitor cells | |
| DK2274419T3 (da) | Fremgangsmåder til fremstilling af hårmikrofollikler og de novopapiller og anvendelse heraf til in vitro-test og in vivo-implantationer | |
| MY146352A (en) | Adipose derived adult stem cells in hepatic regeneration | |
| WO2011025179A3 (en) | Method of inducing the differentiation of human embryonic stem cells into mesenchymal stem cells | |
| WO2012141471A3 (ko) | 역분화-증진제를 이용한 역분화 만능 줄기세포의 제조방법 | |
| WO2011024070A3 (en) | Composition and method for proliferating undifferentiated stem cells | |
| WO2011137540A8 (en) | Gfi1b modulation and uses thereof | |
| WO2011105821A3 (ko) | 무혈청 줄기 세포 배양 조성물, 이를 함유한 조직 재생용 조성물 및 이를 이용한 조직 재생 방법 | |
| WO2007016366A3 (en) | Defined culture conditions of human embryonic stem cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08790919 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 08790919 Country of ref document: EP Kind code of ref document: A1 |